U.S. Food and Drug Administration

Big news for families managing diabetes!

The FDA has cleared the first ever over-the-counter (OTC) continuous glucose monitor (CGM) approved for children 2 and older – Dexcom Inc.’s Stelo Glucose Biosensor System! https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor-children

This wearable sensor pairs with an app on a parent’s or caregiver’s smartphone and automatically measures the child’s glucose every 15 minutes. Each sensor can be worn up to 15 days, depending on sensor life, before needing to be replaced, thus making diabetes management more convenient for the whole family.

The milestone is a powerful example of how real-world evidence (RWE) is informing regulatory decisions and supporting innovation – and it reflects our unwavering commitment to developing gold-standard science that protects the public health.

The FDA believes every child deserves access to safe, effective tools to manage their health – wherever they are.

Total Nutrition expands recall again.

Follow the link for the updated outbreak advisory: https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-moringa-leaf-powder-january-2026

FDA is advising consumers not to eat, sell, or distribute recalled moringa powder dietary supplements sold under the Tnvitamins, Doctor’s Pride, and Mogo brands due to possible Salmonella contamination.

FDA has issued advisories for two Salmonella outbreaks linked to products containing moringa leaf powder.

Check your home and throw these recalled products away.

Learn more:

New Outbreak Advisory for recalled Mogo products: https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-moringa-leaf-powder-may-2026

Updated Outbreak Advisory for recalled Tnvitamins and Doctor’s Pride products: https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-moringa-leaf-powder-january-2026

Looking for a helpful, educational overview of biosimilars? ✅ Check out this article: “9 Things to Know About Biosimilars and Interchangeable Biosimilars.”

https://www.fda.gov/drugs/things-know-about/9-things-know-about-biosimilars-and-interchangeable-biosimilars

Today, the FDA authorized the first generic, over-the-counter treatment for New World screwworm (NWS) in dogs, puppies, cats, and kittens. https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-generic-over-counter-drug-treat-new-world-screwworm-dogs-and

For most cats and dogs in the United States, the risk of NWS is low. Risk is elevated for pets recently in areas with confirmed cases of NWS.

Talk with your veterinarian if you have questions about your pet's risk or how to protect them.

FDA is extending the comment period for the Request for Information on Drug Repurposing for Unmet Medical Needs by 30 days — now open until July 11, 2026! https://www.federalregister.gov/public-inspection/2026-11691/request-for-information-drug-repurposing-for-unmet-medical-needs

Plus, join us for a hybrid public workshop on drug repurposing on August 5th that will cover public docket comments & approaches for prioritizing and selecting repurposing candidates.
Stay tuned for registration details. https://www.reaganudall.org/news-and-events/events/drug-repurposing-unmet-medical-needs

FDA is calling on patients, clinicians, researchers, and other stakeholders to help identify new uses for already-approved drugs, particularly for diseases and conditions with significant unmet medical need. This includes metabolic diseases, neurodegenerative conditions, women's and men's health conditions, substance use disorders, and rare diseases. https://www.fda.gov/news-events/press-announcements/fda-advances-drug-repurposing-address-unmet-medical-needs

FDA is seeking input on:
• Priority disease areas with significant unmet need
• Drug candidates where evidence may already support a new use
• Innovative approaches to identifying repurposing opportunities
• Barriers that limit development of repurposed drugs

This initiative reflects a broader commitment to ensuring drug labeling is clinically meaningful for health care providers and patients, and scientifically up to date.

Do not eat, sell or serve recalled requeson/soft ricotta cheese manufactured by Clover Hill Dairy, LLC.

Recalled product was distributed under various brand names in Maryland, New Jersey, New York, North Carolina, Virginia, and D.C.

For more info, visit: https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-listeria-monocytogenes-soft-cheese-june-2026

Do not eat, sell, or serve recalled soft ricotta/requeson cheese. https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-listeria-monocytogenes-soft-cheese-june-2026

Check your fridge and freezer and throw away recalled products, and sanitize any surfaces or containers that may have come into contact with the cheese.

The first new sunscreen active ingredient in 20 years! FDA has added bemotrizinol as a permitted sunscreen active ingredient in Over-the-Counter (OTC) Monograph M020. Learn more: https://www.fda.gov/news-events/press-announcements/fda-expands-sunscreen-options-first-time-20-years

An OTC monograph drug, such as a sunscreen product, can enter the market without an approved drug application if it meets certain requirements, including conditions established in its OTC monograph such as permitted active ingredients, uses, and doses.

The FDA can modify an OTC monograph through an administrative order, and a drug company may start the process by submitting an OTC monograph order request.

This , take charge of your health. Biosimilars—safe and effective alternatives to biologic medicines—may be used to treat chronic conditions like diabetes, arthritis, heart disease, and prostate cancer.

Find free, easy-to-understand resources from the , including fact sheets, infographics, and videos in multiple languages.

https://www.fda.gov/drugs/biosimilars/biosimilars-basics-patients

Do not eat, sell, or serve recalled soft ricotta/requeson cheese. https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-listeria-monocytogenes-soft-cheese-june-2026

Check your fridge and freezer and throw away recalled products, and sanitize any surfaces or containers that may have come into contact with the cheese.